Clinical trial
clinical trial
Pilot study of the efficacy and hepatic safety of raltegravir-based and efavirenz-based regimens when given in combination with tenofovir and emtricitabine in antiretroviral-naïve HIV-infected subjects co-infected with hepatitis C
Intervention
Drug intervention
Intervention Type
drug intervention
has_intervention
Raltegravir-based and Efavirenz-based Regimens when Given in Combination with Tenofovir and Emtricitabine
drug intervention
Raltegravir-based and Efavirenz-based Regimens when Given in Combination with Tenofovir and Emtricitabine
Intervention
intervention
planned process
planned process
process
occurrent
entity
Contact
has contact
has_contact
Shikuma, Cecilia
PI
has PI
has_PI
Topic
has topic
has_topic
hepatitis C
Human immunodeficiency virus infectious disease
Phase
Phase 4 clinical trial
has phase
has_phase
Phase 4
Performed by
human study performed by
human_study_performed_by
Shikuma Laboratory
HIV therapeutics in HIV and hepatitis C coinfection
Additional Topic(s)
has_subject_area
An open-label, randomized clinical trial
Resource Description
resource_description
Treatment-naive individuals aged >18 who are coinfected with HIV and hepatitis C and meet Viet Nam Ministry of Health criteria to inititate antiretroviral therapy (CD4 <250 or WHO stage III or IV disease)
Study Population
study population
has_study_population
2011-02-10T18:07:31.993-06:00
awendicke (Annemarie Wendicke)
2011-07-26T17:00:00.910-05:00
workflow state
Published
mwilson (Melanie Wilson)
Interventional study
Research project
research project
Human Study
human study
human study
planned process
planned process
Quantitative human study
process
occurrent
entity